Amneal Pharmaceuticals, Inc. AMRX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s free cash flow margin?
- Amneal Pharmaceuticals, Inc. (AMRX) reported free cash flow margin of 7.9% in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s free cash flow margin changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s free cash flow margin decreased by 10.9% year-over-year, from 8.9% to 7.9%.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s free cash flow margin?
- Over 3 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s free cash flow margin has grown at a -18.0% compound annual growth rate (CAGR), from 16.2% to 8.9%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.